CXCL13/CXCR5 signaling axis in cancer
The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Abstract
The tumor microenvironment comprises stromal and tumor cells which interact with each other through complex cross-talks that are mediated by a variety of growth factors, cytokines, and chemokines. The chemokine ligand 13 (CXCL13) and its chemokine receptor 5 (CXCR5) are among the key chemotactic factors which play crucial roles in deriving cancer cell biology. CXCL13/CXCR5 signaling axis makes pivotal contributions to the development and progression of several human cancers. In this review, we discuss how CXCL13/CXCR5 signaling modulates cancer cell ability to grow, proliferate, invade, and metastasize. Furthermore, we also discuss the preliminary evidence on context-dependent functioning of this axis within the tumor-immune microenvironment, thus, highlighting its potential dichotomy with respect to anticancer immunity and cancer immune-evasion mechanisms. At the end, we briefly shed light on the therapeutic potential or implications of targeting CXCL13/CXCR5 axis within the tumor microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nagarsheth, N., Wicha, M. S., & Zou, W. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.49 · Cited by 2,206
Breitfeld, D., Ohl, L., Kremmer, E., Ellwart, J., Sallusto, F., Lipp, M., & Förster, R. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.11.1545 · Cited by 1,464
Chiorazzi, N., Rai, K. R., & Ferrarini, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041720 · Cited by 1,296
A chemokine-driven positive feedback loop organizes lymphoid follicles
Ansel, K. M., Ngo, V. N., Hyman, P. L., Luther, S. A., Förster, R., Sedgwick, J. D., Browning, J. L., Lipp, M., & Cyster, J. G. (2000) · Nature · doi:10.1038/35018581 · Cited by 1,278
Cxc Chemokine Receptor 5 Expression Defines Follicular Homing T Cells with B Cell Helper Function
Schaerli, P., Willimann, K., Lang, A. B., Lipp, M., Loetscher, P., & Moser, B. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.11.1553 · Cited by 1,261
Förster, R., Mattis, A. E., Kremmer, E., Wolf, E., Brem, G., & Lipp, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81798-5 · Cited by 1,129
Stromal Cell Networks Regulate Lymphocyte Entry, Migration, and Territoriality in Lymph Nodes
Bajénoff, M., Egen, J. G., Koo, L. Y., Laugier, J. P., Brau, F., Glaichenhaus, N., & Germain, R. N. (2006) · Immunity · doi:10.1016/j.immuni.2006.10.011 · Cited by 963
Lymphoid neogenesis in chronic inflammatory diseases
Aloisi, F., & Pujol-Borrell, R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1786 · Cited by 908
Smyth, M. J., Dunn, G. P., & Schreiber, R. D. (2006) · Advances in Immunology · doi:10.1016/s0065-2776(06)90001-7 · Cited by 870
Legler, D. F., Loetscher, M., Roos, R. S., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.655 · Cited by 837
A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1
Gunn, M. D., Ngo, V. N., Ansel, K. M., Ekland, E. H., Cyster, J. G., & Williams, L. T. (1998) · Nature · doi:10.1038/35876 · Cited by 835
Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5
Allen, C. D. C., Ansel, K. M., Low, C., Lesley, R., Tamamura, H., Fujii, N., & Cyster, J. G. (2004) · Nature Immunology · doi:10.1038/ni1100 · Cited by 802
Lymphoid Neogenesis in Rheumatoid Synovitis
Takemura, S., Braun, A., Crowson, C., Kurtin, P. J., Cofield, R. H., O’Fallon, W. M., Goronzy, J. J., & Weyand, C. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.1072 · Cited by 660
Benzo[ a ]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor
Shimizu, Y., Nakatsuru, Y., Ichinose, M., Takahashi, Y., Kume, H., Mimura, J., Fujii-Kuriyama, Y., & Ishikawa, T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.779 · Cited by 633
Tertiary lymphoid structures in cancer and beyond
Dieu-Nosjean, M.-C., Goc, J., Giraldo, N. A., Sautès-Fridman, C., & Fridman, W. H. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.09.006 · Cited by 617
From pathogenesis to treatment of chronic lymphocytic leukaemia
Zenz, T., Mertens, D., Küppers, R., Döhner, H., & Stilgenbauer, S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2764 · Cited by 553
Chow, M. T., & Luster, A. D. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0160 · Cited by 485
Luther, S. A., Lopez, T., Bai, W., Hanahan, D., & Cyster, J. G. (2000) · Immunity · doi:10.1016/s1074-7613(00)80199-5 · Cited by 468
CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity.
Ansel, K. M., Harris, R. B. S., & Cyster, J. G. (2002) · Immunity · doi:10.1016/s1074-7613(01)00257-6 · Cited by 449
Follicular stromal cells and lymphocyte homing to follicles
(2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.00618.x · Cited by 443
NETWORK COMMUNICATIONS: Lymphotoxins, LIGHT, and TNF
Ware, C. F. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115719 · Cited by 441
CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5
Jiang, B.-C., Cao, D.-L., Zhang, X., Zhang, Z.-J., He, L.-N., Li, C.-H., Zhang, W.-W., Wu, X.-B., Berta, T., Ji, R.-R., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81950 · Cited by 324
Mazzucchelli, L., Blaser, A., Kappeler, A., Schärli, P., Laissue, J. A., Baggiolini, M., & Uguccioni, M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7830 · Cited by 300
Burger, J. A., & Gribben, J. G. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.08.011 · Cited by 285
Shi, K., Hayashida, K., Kaneko, M., Hashimoto, J., Tomita, T., Lipsky, P. E., Yoshikawa, H., & Ochi, T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.650 · Cited by 280
Soria, G., Ofri-Shahak, M., Haas, I., Yaal-Hahoshen, N., Leider-Trejo, L., Leibovich-Rivkin, T., Weitzenfeld, P., Meshel, T., Shabtai, E., Gutman, M., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-130 · Cited by 275
Carlsen, H. S., Baekkevold, E. S., Morton, H. C., Haraldsen, G., & Brandtzaeg, P. (2004) · Blood · doi:10.1182/blood-2004-02-0701 · Cited by 266
Browning, J. L., Allaire, N., Ngam-ek, A., Notidis, E., Hunt, J., Perrin, S., & Fava, R. A. (2005) · Immunity · doi:10.1016/j.immuni.2005.10.002 · Cited by 265
CXC Chemokines in Cancer Angiogenesis and Metastases
(2010) · Advances in Cancer Research · doi:10.1016/s0065-230x(10)06003-3 · Cited by 263
Barone, F., Bombardieri, M., Manzo, A., Blades, M. C., Morgan, P. R., Challacombe, S. J., Valesini, G., & Pitzalis, C. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21062 · Cited by 256
The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity
Müller, G., Höpken, U. E., & Lipp, M. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00073.x · Cited by 251
Hardy, R. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.2749 · Cited by 249
Dupuis, J., Boye, K., Martin, N., Copie-Bergman, C., Plonquet, A., Fabiani, B., Baglin, A.-C., Haioun, C., Delfau-Larue, M.-H., & Gaulard, P. (2006) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200604000-00009 · Cited by 236
Tumor immunosurveillance in human cancers
Mlecnik, B., Bindea, G., Pagès, F., & Galon, J. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9270-7 · Cited by 223
CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma
Rubenstein, J. L., Wong, V. S., Kadoch, C., Gao, H.-X., Barajas, R., Chen, L., Josephson, S. A., Scott, B., Douglas, V., Maiti, M., et al. (2013) · Blood · doi:10.1182/blood-2013-01-476333 · Cited by 223
Regulation of TH2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells
León, B., Ballesteros-Tato, A., Browning, J. L., Dunn, R., Randall, T. D., & Lund, F. E. (2012) · Nature Immunology · doi:10.1038/ni.2309 · Cited by 220
Bürkle, A., Niedermeier, M., Schmitt-Gräff, A., Wierda, W. G., Keating, M. J., & Burger, J. A. (2007) · Blood · doi:10.1182/blood-2007-05-089409 · Cited by 211
Ammirante, M., Shalapour, S., Kang, Y., Jamieson, C. A. M., & Karin, M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416498111 · Cited by 206
Immune responses to malignancies
Whiteside, T. L. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.045 · Cited by 204
Stromal Cell–Immune Cell Interactions
Roozendaal, R., & Mebius, R. E. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101357 · Cited by 204
Smith, J. R., Braziel, R. M., Paoletti, S., Lipp, M., Uguccioni, M., & Rosenbaum, J. T. (2003) · Blood · doi:10.1182/blood-2002-05-1576 · Cited by 196
Role of the microenvironment in chronic lymphocytic leukaemia
Caligaris‐Cappio, F. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04679.x · Cited by 194
Strategies of Tumor Immune Evasion
Seliger, B. (2005) · BioDrugs · doi:10.2165/00063030-200519060-00002 · Cited by 176
The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis
Meraouna, A., Cizeron-Clairac, G., Panse, R. L., Bismuth, J., Truffault, F., Tallaksen, C., & Berrih-Aknin, S. (2006) · Blood · doi:10.1182/blood-2005-06-2383 · Cited by 172
Salomonsson, S., Larsson, P., Tengnér, P., Mellquist, E., Hjelmström, P., & Wahren‐Herlenius, M. (2002) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2002.01058.x · Cited by 172
Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas
Trentin, L., Cabrelle, A., Facco, M., Carollo, D., Miorin, M., Tosoni, A., Pizzo, P., Binotto, G., Nicolardi, L., Zambello, R., et al. (2004) · Blood · doi:10.1182/blood-2003-09-3103 · Cited by 165
Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor
Schimizu, Y. (2000) · Medical Entomology and Zoology · Cited by 164
Carlsen, H. S. (2002) · Gut · doi:10.1136/gut.51.3.364 · Cited by 161
Microenvironmental Interactions and Survival of CLL B-cells
Pedersen, I. M., & Reed, J. C. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190412331272703 · Cited by 158
CXCL13/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics
Sáez de Guinoa, J., Barrio, L., Mellado, M., & Carrasco, Y. R. (2011) · Blood · doi:10.1182/blood-2011-01-332106 · Cited by 153
Panse, J., Friedrichs, K., Marx, A., Hildebrandt, Y., Luetkens, T., Bartels, K., Horn, C., Stahl, T., Cao, Y. W., Milde‐Langosch, K., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604621 · Cited by 145
Biswas, S., Sengupta, S., Chowdhury, S. R., Jana, S., Mandal, G., Mandal, P., Saha, N., Malhotra, V., Gupta, A., Kuprash, D. V., et al. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2811-8 · Cited by 144
CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway
Zhu, Z., Zhang, X., Guo, H., Fu, L. L., Pan, G., & Sun, Y. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2285-y · Cited by 140
Mukaida, N., Sasaki, S., & Baba, T. (2014) · Mediators of Inflammation · doi:10.1155/2014/170381 · Cited by 136
The Role of Chemokines in Promoting Colorectal Cancer Invasion/Metastasis
Itatani, Y., Kawada, K., Inamoto, S., Yamamoto, T., Ogawa, R., Taketo, M., & Sakai, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050643 · Cited by 132
Drug-Loaded Polymeric Nanoparticles for Cancer Stem Cell Targeting
Li, B., Li, Q., Mo, J., & Dai, H. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00051 · Cited by 125
Zhang, Q., Cao, D., Zhang, Z., Jiang, B., & Gao, Y. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0652-1 · Cited by 124
Identification of a Gene Signature for Rapid Screening of Oral Squamous Cell Carcinoma
Ziober, A. F., Patel, K. R., Alawi, F., Gimotty, P. A., Weber, R. S., Feldman, M. M., Chalian, A. A., Weinstein, G. S., Hunt, J. L., & Ziober, B. L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0535 · Cited by 122
Zheng, Z., Cai, Y., Chen, H., Chen, Z., Zhu, D., Zhong, Q., & Xie, W. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00682 · Cited by 115
Chan, C., Shen, D., Hackett, J., Buggage, R. R., & Tuaillon, N. (2003) · Ophthalmology · doi:10.1016/s0161-6420(02)01737-2 · Cited by 115
Chemokine Receptor Signaling and the Hallmarks of Cancer
Lacalle, R. A., Blanco, R., Carmona‐Rodríguez, L., Martín‐Leal, A., Mira, E., & Mañes, S. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.09.011 · Cited by 105
Yu, H., Shahsafaei, A., & Dorfman, D. M. (2008) · American Journal of Clinical Pathology · doi:10.1309/ajcp62wrkerpxdrt · Cited by 104
Garg, R., Blando, J. M., Pérez, C. J., Abba, M. C., Benavides, F. J., & Kazanietz, M. G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.042 · Cited by 104
γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion
Presti, E. L., Pizzolato, G., Corsale, A. M., Caccamo, N., Sireci, G., Dieli, F., & Meraviglia, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01395 · Cited by 103
Ticchioni, M., Essafi, M., Jeandel, P. Y., Davi, F., Cassuto, J. P., Deckert, M., & Bernard, A. (2007) · Oncogene · doi:10.1038/sj.onc.1210519 · Cited by 102
Meijer, J. M., Zeelenberg, I. S., Sipos, B., & Roos, E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1507 · Cited by 100
Pimenta, E., & Barnes, B. (2014) · Cancers · doi:10.3390/cancers6020969 · Cited by 99
Singh, S., Singh, R., Sharma, P., Singh, U. P., Rai, S. N., Chung, L. W. K., Cooper, C. R., Novakovic, K. R., Grizzle, W. E., & Lillard, J. W. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.03.022 · Cited by 99
Lee, H. J., Song, I.-C., Yun, H.-J., Jo, D.-Y., & Kim, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i7.1681 · Cited by 99
Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation
Rivas-Fuentes, S., Salgado-Aguayo, A. R., Belloso, S. P., Rosete, P. G., Alvarado‐Vásquez, N., & Aquino‐Jarquín, G. (2015) · Journal of Cancer · doi:10.7150/jca.12286 · Cited by 97
How the microenvironment wires the natural history of chronic lymphocytic leukemia
Caligaris‐Cappio, F., Bertilaccio, M. T. S., & Scielzo, C. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.06.010 · Cited by 97
Heinig, K., Gätjen, M., Grau, M., Stache, V., Anagnostopoulos, I., Gerlach, K., Niesner, R. A., Cseresnyés, Z., Hauser, A. E., Lenz, P., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0096 · Cited by 96
Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player?
Rotondi, M., Coperchini, F., Latrofa, F., & Chiovato, L. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00314 · Cited by 95
Wang, G., Cheng, X., Zhou, B., Wen, Z., Huang, Y., Chen, H.-B., Li, G., Huang, Z.-L., Zhou, Y., Feng, L., et al. (2015) · eLife · doi:10.7554/elife.09419 · Cited by 95
Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression
Whiteside, T. L. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2010.482207 · Cited by 95
Role of dendritic cell-derived CXCL13 in the pathogenesis of Bartonella henselae B-rich granuloma
Vermi, W., Facchetti, F., Riboldi, E., Heine, H., Scutera, S., Stornello, S., Ravarino, D., Cappello, P., Giovarelli, M., Badolato, R., et al. (2005) · Blood · doi:10.1182/blood-2005-04-1342 · Cited by 88
El-Haibi, C. P., Singh, R., Sharma, P., Singh, S., & Lillard, J. W. (2011) · Cell Proliferation · doi:10.1111/j.1365-2184.2011.00757.x · Cited by 87
Vachani, A., Nebozhyn, M., Singhal, S. K., Alila, L., Wakeam, E., Muschel, R. J., Powell, C. A., Gaffney, P. M., Singh, B., Brose, M. S., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1670 · Cited by 83
Husson, H., Freedman, A. S., Cardoso, A. A., Schultze, J. L., Muñoz, O., Strola, G., Kutok, J. L., Carideo, E. G., de Beaumont, R., Caligaris‐Cappio, F., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03832.x · Cited by 82
CXCR5+ CD8+ T cells potently infiltrate pancreatic tumors and present high functionality
Bai, M., Zheng, Y., Liu, H., Su, B., Zhan, Y., & He, H. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.09.039 · Cited by 79
Wu, X., Cao, D., Zhang, X., Jiang, B., Zhao, L., Qian, B., & Gao, Y. (2016) · Scientific Reports · doi:10.1038/srep34836 · Cited by 78
Cell Trafficking in Chronic Lymphocytic Leukemia
Davids, M. S., & Burger, J. A. (2012) · Open Journal of Hematology · doi:10.13055/ojhmt_3_s1_03.120221 · Cited by 77
Association of Cytokines and Chemokines in Pathogenesis of Breast Cancer
King, J., Mir, H., & Singh, S. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.07.003 · Cited by 74
Lung Tumor Microenvironment Induces Specific Gene Expression Signature in Intratumoral NK Cells
Gillard, M., Caer, C., Cagnard, N., Crozet, L., Perez, M., Fridman, W. H., Sautès‐Fridman, C., & Cremer, I. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00019 · Cited by 73
Aust, G., Sittig, D., Becherer, L., Anderegg, U., Schutz, A., Lamesch, P., & Schmucking, E. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500225 · Cited by 73
Concerted action of the chemokine and lymphotoxin system in secondary lymphoid-organ development
Müller, G., & Lipp, M. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00014-1 · Cited by 73
Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma
Brunn, A., Montesinos‐Rongen, M., Strack, A., Reifenberger, G., Mawrin, C., Schaller, C., & Deckert, M. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0258-x · Cited by 71
Jifu, E., Yan, F., Kang, Z., Zhu, L., Xing, J., & Yu, E. (2018) · Human Immunology · doi:10.1016/j.humimm.2018.03.003 · Cited by 68
Role of chemokines in ectopic lymphoid structures formation in autoimmunity and cancer
Nerviani, A., & Pitzalis, C. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0218-062r · Cited by 68
Chemokines: key players in cancer progression and metastasis
Singh, R. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/246 · Cited by 66
Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines
Singh, S., Singh, R., Singh, U. P., Rai, S. N., Novakovic, K. R., Chung, L. W. K., Didier, P. J., Grizzle, W. E., & Lillard, J. W. (2009) · International Journal of Cancer · doi:10.1002/ijc.24574 · Cited by 66
El-Haibi, C. P., Sharma, P., Singh, R., Johnson, P. R., Suttles, J., Singh, S., & Lillard, J. W. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-85 · Cited by 65
Sambandam, Y., Sundaram, K., Liu, A., Kirkwood, K. L., Ries, W. L., & Reddy, S. V. (2012) · Oncogene · doi:10.1038/onc.2012.24 · Cited by 61
C-Src-mediated RANKL-induced breast cancer cell migration by activation of the ERK and Akt pathway
Zhang, L., Teng, Y., Zhang, Y., LIU, J., Xu, L., Qu, J., Hou, K., Yang, X., Liu, Y., & Qu, X. (2011) · Oncology Letters · doi:10.3892/ol.2011.487 · Cited by 61
Self-citationCXCR5 may be involved in the attraction of human metastatic neuroblastoma cells to the bone marrow
Airoldi, I., Cocco, C., Morandi, F., Prigione, I., & Pistoia, V. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0392-2 · Cited by 60
Lymphoid chemokines in chronic neuroinflammation
Aloisi, F., Cabezas, S. C., Franciotta, D. M., Rosicarelli, B., Magliozzi, R., Reynolds, R., Ambrosini, E., Coccia, E. M., Salvetti, M., & Serafini, B. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.025 · Cited by 60
Badr, G., Al-Sadoon, M. K., & Rabah, D. M. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.018 · Cited by 60
Höpken, U. E., Achtman, A. H., Krüger, K., & Lipp, M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1203643 · Cited by 59
Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment
Weinstein, A. M., & Storkus, W. J. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2015.04.003 · Cited by 58
Hussain, S. K., Zhu, W., Chang, S., Breen, E. C., Vendrame, E., Magpantay, L. I., Widney, D., Conn, D. J., Sehl, M. E., Jacobson, L. P., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1122 · Cited by 58
Chen, X., Takemoto, Y., Deng, H., Middelhoff, M. A., Friedman, R. A., Chu, T. H., Churchill, M., Ma, Y., Nagar, K. K., Tailor, Y. H., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1290034 · Cited by 57
Regulatory and Pathogenic Mechanisms in Human Autoimmune Myasthenia Gravis
Panse, R. L., Cizeron-Clairac, G., Cuvelier, M. F., Truffault, F., Bismuth, J., Nancy, P., de Rosbo, N. K., & Berrih‐Aknin, S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1405.019 · Cited by 57
Razis, E. D., Kalogeras, K. T., Kotoula, V., Eleftheraki, A. G., Nikitas, N., Kronenwett, R., Timotheadou, E. T., Christodoulou, C., Pectasides, D. G., Gogas, H. J., et al. (2012) · Clinical Breast Cancer · doi:10.1016/j.clbc.2012.03.006 · Cited by 56
Chen, L., Huang, Z., Yao, G., Lyu, X., Li, J., Hu, X., Cai, Y., Li, W., Li, X., & Ye, C. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0521-1 · Cited by 55
CD40 controls CXCR5-induced recruitment of myeloid-derived suppressor cells to gastric cancer
Ding, Y., Shen, J., Zhang, G., Chen, X., Wu, J., & Chen, W. (2015) · Oncotarget · doi:10.18632/oncotarget.5644 · Cited by 54
Wei, Y., Lin, C., Li, H., Xu, Z., Wang, J., Li, R., Liu, H., Zhang, H., He, H., & Xu, J. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2083-y · Cited by 52
p53-dependent expression of CXCR5 chemokine receptor in MCF-7 breast cancer cells
Mitkin, N. A., Hook, C., Schwartz, A. M., Biswas, S., Кочетков, Д. В., Muratova, A. M., Afanasyeva, M., Kravchenko, J. E., Bhattacharyya, A., & Kuprash, D. V. (2015) · Scientific Reports · doi:10.1038/srep09330 · Cited by 52
Yamamoto, K., Nishiumi, S., Yang, L., Klimatcheva, E., Pandina, T., Takahashi, S., Matsui, H., Nakamura, M., Zauderer, M., Yoshida, M., et al. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.14 · Cited by 50
Coelho, F. M., Natale, D., Soriano, S. F., Hons, M., Swoger, J., Mayer, J., Danuser, R., Scandella, E., Pieczyk, M., Zerwes, H., et al. (2013) · Blood · doi:10.1182/blood-2012-10-465336 · Cited by 50
Chemokines and their receptors in lung cancer progression and metastasis
Cheng, Z., Shi, Y., Yuan, M., Xiong, D., Zheng, J.-H., & Zhang, Z. (2016) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1500258 · Cited by 49
The role of chemokines in cancer immune surveillance by the adaptive immune system
Krieg, C., & Boyman, O. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.10.011 · Cited by 47
Badr, G., Al-Sadoon, M. K., Rabah, D. M., & Sayed, D. M. (2012) · APOPTOSIS · doi:10.1007/s10495-012-0787-1 · Cited by 47
Differential G protein subunit expression by prostate cancer cells and their interaction with CXCR5
El-Haibi, C. P., Sharma, P., Singh, R., Gupta, P., Taub, D. D., Singh, S., & Lillard, J. W. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-64 · Cited by 46
Xing, J., Zhang, C., Yang, X., Wang, S., Wang, Z., Xu, L., & Yu, E. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.04.014 · Cited by 45
A Novel Function of CXCL13 to Stimulate RANK Ligand Expression in Oral Squamous Cell Carcinoma Cells
Sambandam, Y., Griffin, A. C., Sundaram, K., Kirkwood, K. L., Norris, J. S., & Reddy, S. V. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0589 · Cited by 45
Pimenta, E. M., De, S., Weiss, R., Feng, D., Hall, K. L., Kilic, S. S., Bhanot, G., Ganesan, S., Ran, S., & Barnes, B. J. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.110 · Cited by 44
Mechanisms of tumor evasion from the immune response
Rodríguez, P. C., Zea, A. H., & Ochoa, A. C. (2003) · Cancer chemotherapy and biological response modifiers · doi:10.1016/s0921-4410(03)21018-8 · Cited by 44
The Emerging Role of CXC Chemokines And Their Receptors in Cancer
Vinader, V. M., & Afarinkia, K. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.48 · Cited by 42
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis
Charbonneau, B., Wang, A. H., Maurer, M. J., Asmann, Y. W., Zent, C. S., Link, B. K., Ansell, S. M., Weiner, G. J., Özsan, N., Feldman, A. L., et al. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1452-4 · Cited by 41
Pandruvada, S. N. M., Sambandam, Y., Liu, X., Sundaram, K., Shanmugarajan, S., Ries, W. L., Norris, J. S., London, S. D., & Reddy, S. V. (2009) · International Journal of Cancer · doi:10.1002/ijc.24920 · Cited by 41
Müller, G., & Lipp, M. (2001) · Biological Chemistry · doi:10.1515/bc.2001.171 · Cited by 41
Widney, D. P., Gui, D., Popoviciu, L. M., et al. (2010) · AIDS Research and Treatment · doi:10.1155/2010/164586 · Cited by 38
Cha, Z., Qian, G., Zang, Y., Gu, H., Huang, Y., Zhu, L., Li, J., Liu, Y., Tu, X., Song, H., et al. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.11.017 · Cited by 38
Yoshie, O. (2000) · Springer Seminars in Immunopathology · doi:10.1007/s002810000051 · Cited by 36
Kim, S. J., Ryu, K. J., Hong, M. E., Ko, Y. H., & Kim, W. S. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0142-4 · Cited by 36
CXCR5+CD8+ T cells could induce the death of tumor cells in HBV-related hepatocellular carcinoma
Jin, Y., Lang, C., Tang, J., Geng, J., Song, H., Sun, Z., & Wang, J. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.10.009 · Cited by 35
Inflammation, the microenvironment and chronic lymphocytic leukemia
Caligaris‐Cappio, F. (2011) · Haematologica · doi:10.3324/haematol.2010.039446 · Cited by 35
Fan, L., Zhu, Q., Liu, L., Zhu, C., Huang, H., Lu, S., & Liu, P. (2017) · Oncotarget · doi:10.18632/oncotarget.18387 · Cited by 31
Cha, Z., Gu, H., Zang, Y., Wang, Z., Li, J., Huang, W., Qin, A., Zhu, L., Tu, X., Cheng, N., et al. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.05.025 · Cited by 31
Signaling via the CXCR5/ERK pathway is mediated by CXCL13 in mice with breast cancer
Xu, L., Liang, Z., Li, S., & Ma, J. (2018) · Oncology Letters · doi:10.3892/ol.2018.8510 · Cited by 31
Halvorsen, B. L., Smedbakken, L. M., Michelsen, A. E., Skjelland, M., Bjerkeli, V., Sagen, E. L., Taskén, K., Bendz, B., Gullestad, L. L., Holm, S., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.03.021 · Cited by 31
Tang, J.-H., Zha, J., Guo, X., Shi, P., & Xu, B. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.06.020 · Cited by 30
Höpken, U. E., & Rehm, A. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0906-z · Cited by 29
Grosso, F., Coco, S., Scaruffi, P., et al. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0367 · Cited by 28
Nedelkovska, H., Rosenberg, A. F., Hilchey, S. P., Hyrien, O., Burack, R., Quataert, S. A., Baker, C. M., Azadniv, M., Welle, S. L., Ansell, S. M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155347 · Cited by 28
Zhou, Y., Guo, L., Sun, H., Xu, J., & Ba, T. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.07.002 · Cited by 26
Ohtani, H., Komeno, T., Agatsuma, Y., Kobayashi, M., Noguchi, M., & Nakamura, N. (2015) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt.55.61 · Cited by 24
p53 Deletion promotes myeloma cells invasion by upregulating miR19a/CXCR5
Yue, Z., Zhou, Y., Zhao, P., Chen, Y., Yuan, Y., Jing, Y., & Wang, X. (2017) · Leukemia Research · doi:10.1016/j.leukres.2017.07.003 · Cited by 19
The role of selected chemokines and their specific receptors in pancreatic cancer
Łukaszewicz‐Zając, M., Gryko, M., & Mroczko, B. (2018) · The International Journal of Biological Markers · doi:10.1177/1724600817753094 · Cited by 18
Wang, X., He, Y., Yanping, J., Xinti, T., Yang, Y., Yu, F., Ruijin, X., Li, W., Chen, L., Jingyi, L., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2880 · Cited by 18
Mitkin, N. A., Muratova, A. M., Sharonov, G. V., Korneev, K. V., Sviriaeva, E. N., Mazurov, D. V., Schwartz, A. M., & Kuprash, D. V. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.10.003 · Cited by 16
Chemokines key players in cancer progression and metastasis
Singh, S. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/s246 · Cited by 11
Stache, V., Verlaat, L., Gätjen, M., Heinig, K., Westermann, J., Rehm, A., & Höpken, U. E. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1323155 · Cited by 8
Cited by
Sun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,014
Zhao, S., Mi, Y., Guan, B., Zheng, B., Wei, P., Gu, Y., Zhang, Z., Cai, S., Xu, Y., Li, X., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00991-2 · Cited by 778
Metadata
- Authors
- Hussain, M., Adah, D., Tariq, M., Lu, Y., Zhang, J., & Liu, J.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 227
- Pages
- 175-186
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2940666965
- Cited by
- 204
- References
- 143
- FWCI
- 9.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.